Julien Mazières

机构：Université Toulouse III - Paul Sabatier, Université Fédérale de Toulouse Midi-Pyrénées, Centre Hospitalier Universitaire de Toulouse, Centre de Recherches en Cancérologie de Toulouse, Hôpital Larrey, Institut Claudius Regaud · ORCID：0000-0002-5921-7613

发表论文 995 篇 · 总被引 49838 次 · h-index 91

代表论文

• Air pollution and lung cancer: a comprehensive review (2025 · Journal of Epidemiology and Population Health · 被引 5)
• Biology and Clinical Management of Non-V600 BRAF Alterations in NSCLC (2026 · Journal of Thoracic Oncology · 被引 2)
• Long-term efficacy and safety of lorlatinib versus alectinib in anaplastic lymphoma kinase-positive advanced/metastatic non-small cell lung cancer: matching-adjusted indirect comparison (2025 · Journal of Comparative Effectiveness Research · 被引 1)
• Efficacy of Neratinib-Based Therapy in ERBB2-Mutant Lung Adenocarcinomas: Findings From 2 International Phase 2 Studies (2025 · Clinical Lung Cancer · 被引 1)
• Patient-reported outcomes with tarlatamab in extensive-stage small cell lung cancer after platinum-based chemotherapy: results from the phase 3 DeLLphi-304 trial (2026 · Lung Cancer)
• Circulating epigenetic and epitranscriptomic biomarkers identify EGFR status, predict TKI response and reveal therapeutic vulnerabilities in NSCLC (2026 · Scientific Reports)